Page last updated: 2024-11-05

tolazoline and Anemia, Sickle Cell

tolazoline has been researched along with Anemia, Sickle Cell in 2 studies

Tolazoline: A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn.
tolazoline : A member of the class of imidazoles that is 4,5-dihydro-1H-imidazole substituted by a benzyl group.

Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SMITH, E1
ROSENBLATT, P1
BEDO, AV1
Chang, H1
Ewert, SM1
Nagel, RL1

Other Studies

2 other studies available for tolazoline and Anemia, Sickle Cell

ArticleYear
Sickle-cell anemia crisis; report on seven patients treated with priscoline.
    The Journal of pediatrics, 1953, Volume: 43, Issue:6

    Topics: Anemia; Anemia, Sickle Cell; Erythrocytes, Abnormal; Humans; Sympatholytics; Tolazoline

1953
Identification of 2-imidazolines as anti-sickling agents.
    Molecular pharmacology, 1983, Volume: 23, Issue:3

    Topics: Anemia, Sickle Cell; Antisickling Agents; Clonidine; Gels; Hemoglobin, Sickle; Humans; Imidazoles; K

1983
chemdatabank.com